高位跳水近30%后继续上行,“被带崩”后的昭衍新药走向下一个新高?

智通财经网
04 Jul

最近,借着港股创新药的一波大涨行情,昭衍新药(06127)股价触及19.49港元,这一股价在突破今年3月前高的同时,也创下自2023年9月以来的股价新高。但实际上,昭衍新药此次股价新高之路并不平坦。今年4月,港股整体大震荡叠加FDA宣布计划逐步取消单抗和其他药物的动物实验要求,昭衍新药当月股价一度大跌近30%,但在5月港股创新药行情推动下,昭衍新药股价又迅速反弹,月度涨幅又超过40%,在市场情绪...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10